CN114875098B - Kit for carrying out seamless assembly on multiple DNA fragments and assembly vector and application method thereof - Google Patents
Kit for carrying out seamless assembly on multiple DNA fragments and assembly vector and application method thereof Download PDFInfo
- Publication number
- CN114875098B CN114875098B CN202210749493.3A CN202210749493A CN114875098B CN 114875098 B CN114875098 B CN 114875098B CN 202210749493 A CN202210749493 A CN 202210749493A CN 114875098 B CN114875098 B CN 114875098B
- Authority
- CN
- China
- Prior art keywords
- assembly
- kit
- dna
- application method
- dna fragments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012634 fragment Substances 0.000 title claims abstract description 102
- 238000000034 method Methods 0.000 title claims abstract description 53
- 239000013598 vector Substances 0.000 title description 14
- 108020004414 DNA Proteins 0.000 claims abstract description 56
- 108060002716 Exonuclease Proteins 0.000 claims abstract description 26
- 102000013165 exonuclease Human genes 0.000 claims abstract description 26
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims abstract description 21
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims abstract description 17
- 101710116602 DNA-Binding protein G5P Proteins 0.000 claims abstract description 16
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims abstract description 16
- 101710162453 Replication factor A Proteins 0.000 claims abstract description 16
- 101710176758 Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 claims abstract description 16
- 101710176276 SSB protein Proteins 0.000 claims abstract description 16
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims description 28
- 239000000872 buffer Substances 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 12
- 238000011534 incubation Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 108010002747 Pfu DNA polymerase Proteins 0.000 claims description 2
- 108010006785 Taq Polymerase Proteins 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 1
- 238000010367 cloning Methods 0.000 abstract description 10
- 238000005215 recombination Methods 0.000 abstract description 9
- 230000006798 recombination Effects 0.000 abstract description 9
- 238000005516 engineering process Methods 0.000 abstract description 4
- 238000000338 in vitro Methods 0.000 abstract description 4
- 239000007853 buffer solution Substances 0.000 abstract 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 9
- 239000000499 gel Substances 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 102000014914 Carrier Proteins Human genes 0.000 description 6
- 108010014594 Heterogeneous Nuclear Ribonucleoprotein A1 Proteins 0.000 description 6
- 108091008324 binding proteins Proteins 0.000 description 6
- 108091012434 DNA polymerase binding proteins Proteins 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007702 DNA assembly Methods 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010055016 Rec A Recombinases Proteins 0.000 description 1
- 102000001218 Rec A Recombinases Human genes 0.000 description 1
- 101150104425 T4 gene Proteins 0.000 description 1
- 229960001456 adenosine triphosphate Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000007500 overflow downdraw method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 108700014590 single-stranded DNA binding proteins Proteins 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及生物化学与分子生物学技术领域,尤其涉及DNA片段进行无缝组装的试剂盒。The invention relates to the technical fields of biochemistry and molecular biology, in particular to a kit for seamlessly assembling DNA fragments.
背景技术Background technique
分子克隆技术作为现代分子生物学实验室的必备技术,一直以来都是实现基因鉴定、研究基因表达和基因生物学功能分析的基础方法,随着人们对基因组中的非编码序列的深入研究,对于调控元件序列的克隆和功能解析越来越受到关注。传统的分子克隆常常基于使用相同的限制性内切酶酶切载体和目的片段,使得载体和目的片段具有相同的粘性末端或平末端,进而使用T4 DNA连接酶对其进行体外连接实现不同DNA片段的组装。但是酶切连接方法不仅低效耗时,而且具有序列依赖、序列残留和难以实现高通量操作等弊端。此外现代分子实验室占据越来越多主流地位的基于单链退火拼接的方法,这类方法不受限制性酶切位点的限制,包括SLIC、Gibson Assembly、In-Fusion、Hot Fusion和TEDA等。Molecular cloning technology, as an essential technology in modern molecular biology laboratories, has always been the basic method for gene identification, gene expression research and gene biological function analysis. With the in-depth study of non-coding sequences in the genome, More and more attention has been paid to the cloning and functional analysis of regulatory element sequences. Traditional molecular cloning is often based on the use of the same restriction endonuclease to digest the vector and the target fragment, so that the vector and the target fragment have the same sticky end or blunt end, and then use T4 DNA ligase to connect them in vitro to achieve different DNA fragments assembly. However, the enzymatic ligation method is not only inefficient and time-consuming, but also has disadvantages such as sequence dependence, sequence residue, and difficulty in achieving high-throughput operations. In addition, modern molecular laboratories occupy more and more mainstream methods based on single-strand annealing and splicing, which are not limited by restriction enzyme sites, including SLIC, Gibson Assembly, In-Fusion, Hot Fusion and TEDA, etc. .
上述方法中一部分方法需要专利重组酶等,导致价格昂贵,还有一部分方法所需蛋白种类多,增加实验成本,而且上述方法组装效率和正确率会随着组装片段数量的增加而降低,仍具有优化的空间。Some of the above methods require patented recombinant enzymes, etc., resulting in high prices, and some methods require many types of proteins, which increases the cost of the experiment. Moreover, the assembly efficiency and correct rate of the above methods will decrease with the increase in the number of assembled fragments, and still have Optimized space.
发明内容Contents of the invention
本发明的目的在于提供一种将多个DNA片段和组装载体进行无缝组装的试剂盒和应用方法,本发明所述的技术方案能够优化的实现多个DNA片段的无缝组装,又可达到非常高的重组效率和低背景率。The purpose of the present invention is to provide a kit and application method for seamlessly assembling multiple DNA fragments and assembly vectors. The technical scheme described in the present invention can optimize the seamless assembly of multiple DNA fragments, and can also achieve Very high recombination efficiency and low background rate.
为了实现上述发明目的,本发明提供以下技术方案:In order to achieve the above-mentioned purpose of the invention, the present invention provides the following technical solutions:
本发明提供了一种将多个DNA片段和组装载体进行无缝组装的试剂盒,所述试剂盒包括T5核酸外切酶、DNA聚合酶、单链DNA结合蛋白和组装缓冲液。The invention provides a kit for seamlessly assembling multiple DNA fragments and assembly vectors, the kit includes T5 exonuclease, DNA polymerase, single-stranded DNA binding protein and assembly buffer.
作为优选,所述T5核酸外切酶的使用浓度为0.001-0.005U/μl;所述DNA聚合酶的使用浓度为0.010-0.030U/μl;所述单链DNA结合蛋白的使用浓度为0.001-0.005μg/μl。As preferably, the use concentration of the T5 exonuclease is 0.001-0.005U/μl; the use concentration of the DNA polymerase is 0.010-0.030U/μl; the use concentration of the single-stranded DNA binding protein is 0.001-0.001- 0.005 μg/μl.
作为优选,所述组装缓冲液为Pre-assembly buffer。本发明中T5核酸外切酶、DNA聚合酶和单链DNA结合蛋白可在体外实现无缝组装,得到有亚稳态结构的环状的目的质粒;T5核酸外切酶的3’-5’外切酶活性切割DNA片段末端暴露单链互补同源臂区域,末端上的短同源序列退火使得载体和插入DNA片段较为紧密的连在一起,形成具有缺口的环状质粒,转化进入大肠杆菌后依赖细胞自身修复机制完成质粒的缺口修复;DNA聚合酶则延5’-3’对同源臂区域附近的缺失DNA进行修复,以在体外形成稳定存在的包含缺口的亚质粒结构;单链DNA结合蛋白可参与维持外切酶切割形成的ssDNA末端的完整性和稳定性,极大地提升多DNA片段组装或具发卡结构末端的DNA片段的组装效率。Preferably, the assembly buffer is Pre-assembly buffer. In the present invention, T5 exonuclease, DNA polymerase and single-stranded DNA binding protein can be seamlessly assembled in vitro to obtain a circular target plasmid with a metastable structure; the 3'-5' of T5 exonuclease The exonuclease activity cuts the end of the DNA fragment to expose the single-stranded complementary homology arm region, and the short homologous sequence on the end anneals to make the vector and the inserted DNA fragment closely connected together to form a circular plasmid with a gap, which is transformed into E. coli Then rely on the cell's own repair mechanism to complete the gap repair of the plasmid; DNA polymerase repairs the missing DNA near the homology arm region along the 5'-3' to form a stable subplasmid structure containing the gap in vitro; single-stranded DNA-binding proteins can participate in maintaining the integrity and stability of ssDNA ends formed by exonuclease cleavage, greatly improving the assembly efficiency of multiple DNA fragments or DNA fragments with hairpin ends.
作为优选,所述DNA片段的两端具有与相邻DNA片段同源的同源臂序列,且同源臂序列长度为9bp-50bp。Preferably, both ends of the DNA fragment have homologous arm sequences that are homologous to adjacent DNA fragments, and the length of the homologous arm sequences is 9bp-50bp.
本发明还提供了一种所述试剂盒的应用方法,所述应用方法为:将30-50ng/μl线性化的载体、多个20-100ng/μl DNA片段加入到无缝组装体系中进行组装反应。The present invention also provides an application method of the kit, the application method is: adding 30-50ng/μl linearized vector and multiple 20-100ng/μl DNA fragments into the seamless assembly system for assembly reaction.
作为优选,所述无缝组装体系包括试剂盒中的T5核酸外切酶、DNA聚合酶、单链DNA结合蛋白、组装缓冲液和水。Preferably, the seamless assembly system includes T5 exonuclease, DNA polymerase, single-stranded DNA binding protein, assembly buffer and water in the kit.
作为优选,所述线性化载体为1ng-300ng用量时,线性化载体与DNA片段间的摩尔比为1:1-1:10。Preferably, when the linearized carrier is used in an amount of 1ng-300ng, the molar ratio between the linearized carrier and the DNA fragment is 1:1-1:10.
作为优选,所述组装反应总反应体系以20μl计,包括以下组分:As a preference, the total reaction system of the assembly reaction includes the following components in 20 μl:
作为优选,所述2×无缝组装体系以400μl计,包括以下组分:As a preference, the 2×seamless assembly system includes the following components in 400 μl:
作为优选,所述组装反应的程序为:50±10℃孵育0.1-1.0h后,降温至4℃。Preferably, the procedure of the assembly reaction is: after incubating at 50±10°C for 0.1-1.0h, the temperature is lowered to 4°C.
通过采用上述技术方案,本发明具有如下有益效果:By adopting the above technical scheme, the present invention has the following beneficial effects:
1.本发明技术方案提供的试剂盒可以实现多个DNA片段的无缝克隆组装连接,相对于其他DNA连接技术不仅不受限制性酶切位点的限制,无需附加特定的重组位点,实现真正意义上的无缝克隆,而且在多DNA片段组装的情况下仍具有较高的组装效率和正确率。1. The kit provided by the technical solution of the present invention can realize the seamless cloning, assembly and connection of multiple DNA fragments. Compared with other DNA connection techniques, it is not limited by restriction enzyme sites, and does not need to add specific recombination sites to realize In the true sense of seamless cloning, it still has high assembly efficiency and correct rate in the case of multiple DNA fragment assembly.
2.本发明中单链DNA结合蛋白的应用,极大地提升多DNA片段组装或具发卡结构末端的DNA片段的组装效率,实现了高效精准的无缝克隆,增加了DNA组装的成功率和应用前景。尤其是涉及超过4个DNA片段的组装提升效果更明显。2. The application of the single-stranded DNA binding protein in the present invention greatly improves the assembly efficiency of multiple DNA fragments or DNA fragments with hairpin ends, realizes efficient and accurate seamless cloning, and increases the success rate and application of DNA assembly prospect. Especially the assembly improvement effect involving more than 4 DNA fragments is more obvious.
3.本发明所述的技术方案不仅高效优质,而且高性价比、原理简单、操作方便、适用范围广。3. The technical solution of the present invention is not only efficient and high-quality, but also cost-effective, simple in principle, convenient in operation and wide in application.
附图说明Description of drawings
图1为本发明TSP组装技术的原理示意图;Fig. 1 is the schematic diagram of the principle of TSP assembly technology of the present invention;
图2为实施例1制得的质粒图谱;Fig. 2 is the plasmid map that embodiment 1 makes;
图3为TP和TSP方法克隆过程相关结果(其中A为质粒载体所选6个片段的电泳胶图;B为TP和TSP方法下分别进行两片段、三片段和四片段组装的相应克隆形成数示意图;C为TP和TSP方法下分别进行两片段、三片段、四片段组装的相应克隆形成片段的电泳胶图。);Figure 3 is the results related to the cloning process of TP and TSP methods (wherein A is the electrophoretic gel image of the 6 fragments selected by the plasmid vector; B is the number of corresponding clones formed by two-fragment, three-fragment and four-fragment assembly under TP and TSP methods respectively Schematic diagram; C is the electrophoretic gel map of the fragments formed by the corresponding clones assembled by two-fragment, three-fragment, and four-fragment respectively under TP and TSP methods);
图4为实施例2制得的质粒图谱;Fig. 4 is the plasmid map that embodiment 2 makes;
图5为TEDA、TP、GA和TSP方法克隆过程相关结果(其中A为质粒载体所选6个片段的电泳胶图;B为TEDA、TP、GA和TSP方法下分别进行六片段组装的相应克隆形成数示意图;C为TSP方法下在10分钟、20分钟、40分钟和60分钟等不同处理时间下的相应克隆形成数示意图;D为TEDA、TP、GA和TSP方法下分别进行六片段组装的相应克隆形成片段的电泳胶图)。Figure 5 is the results related to the cloning process of TEDA, TP, GA and TSP methods (where A is the electrophoretic gel image of the six fragments selected by the plasmid vector; B is the corresponding clone of the six fragments assembled under the TEDA, TP, GA and TSP methods respectively Schematic diagram of the formation number; C is a schematic diagram of the corresponding colony formation number under different treatment times such as 10 minutes, 20 minutes, 40 minutes and 60 minutes under the TSP method; D is the six-fragment assembly under the TEDA, TP, GA and TSP methods respectively Electrophoresis gel images of fragments formed by the corresponding clones).
具体实施方式Detailed ways
本发明提供了一种将多个DNA片段和组装载体进行无缝组装的试剂盒,所述试剂盒包括T5核酸外切酶、DNA聚合酶、单链DNA结合蛋白和组装缓冲液。The invention provides a kit for seamlessly assembling multiple DNA fragments and assembly vectors, the kit includes T5 exonuclease, DNA polymerase, single-stranded DNA binding protein and assembly buffer.
在本发明中,所述DNA聚合酶为常见的具外切酶活性的耐热DNA聚合酶,优选的包括具有5’-3’外切酶活性的Taq DNA聚合酶或具有3’-5’外切酶活性的Pfu DNA聚合酶。In the present invention, the DNA polymerase is a common thermostable DNA polymerase with exonuclease activity, preferably Taq DNA polymerase with 5'-3' exonuclease activity or a 3'-5' Pfu DNA polymerase with exonuclease activity.
在本发明中,所述单链DNA结合蛋白优选的包括极端耐热单链DNA结合蛋白(ET-SSB蛋白)、RecA、T4基因32单链结合蛋白及大肠杆菌单链DNA结合蛋白中的任一种。In the present invention, the single-stranded DNA binding protein preferably includes any of the extreme heat-resistant single-stranded DNA binding protein (ET-SSB protein), RecA, T4 gene 32 single-stranded DNA binding protein and E. coli single-stranded DNA binding protein. A sort of.
在本发明中,所述T5核酸外切酶的使用浓度优选为0.001-0.005U/μl,进一步的优选为0.004U/μl;所述DNA聚合酶的使用浓度优选为0.010-0.030U/μl,进一步的优选为0.025U/μl;所述单链DNA结合蛋白的使用浓度优选为0.001-0.005U/μl,进一步的优选为0.003μg/μl。In the present invention, the use concentration of the T5 exonuclease is preferably 0.001-0.005U/μl, further preferably 0.004U/μl; the use concentration of the DNA polymerase is preferably 0.010-0.030U/μl, It is further preferably 0.025 U/μl; the concentration of the single-stranded DNA binding protein used is preferably 0.001-0.005 U/μl, further preferably 0.003 μg/μl.
在本发明中,所述组装缓冲液为Pre-assemblybuffer,具体包括pH=7.5的Tris-HCl、10mM MgCl2、10mM DTT、0.2mM dNTP Mix和质量比为5%的PEG8000,还可优选的加入1-10mg/l NaCl、0.1-10mg/l EDTA、10-200g/l甘油、10-50mg/l牛血清白蛋白、0.1-10mg/l腺苷-5’-三磷酸中的任一种。In the present invention, the assembly buffer is Pre-assembly buffer, which specifically includes Tris-HCl with pH=7.5, 10mM MgCl 2 , 10mM DTT, 0.2mM dNTP Mix and PEG8000 with a mass ratio of 5%. Any of 1-10mg/l NaCl, 0.1-10mg/l EDTA, 10-200g/l glycerin, 10-50mg/l bovine serum albumin, 0.1-10mg/l adenosine-5'-triphosphate.
本发明还提供了一种所述试剂盒的应用方法,所述应用方法为:将30-50ng/μl线性化的载体、多个20-100ng/μl DNA片段加入到无缝组装体系中进行组装反应;当DNA片段优选为2个时,DNA片段的浓度优选为30-100ng/μl;当DNA片段优选为3-4个时,DNA片段的浓度优选为20-50ng/μl;当DNA片段优选为6个时,DNA片段的浓度优选为20-50ng/μl。The present invention also provides an application method of the kit, the application method is: adding 30-50ng/μl linearized vector and multiple 20-100ng/μl DNA fragments into the seamless assembly system for assembly Reaction; when there are preferably 2 DNA fragments, the concentration of the DNA fragments is preferably 30-100ng/μl; when the DNA fragments are preferably 3-4, the concentration of the DNA fragments is preferably 20-50ng/μl; when the DNA fragments are preferably When there are 6 DNA fragments, the concentration of DNA fragments is preferably 20-50 ng/μl.
在本发明中,所述DNA片段的两端具有与相邻DNA片段同源的同源臂序列,且同源臂序列长度优选为9bp-50bp,进一步的优选为20bp-30bp。In the present invention, both ends of the DNA fragment have homology arm sequences homologous to adjacent DNA fragments, and the length of the homology arm sequence is preferably 9bp-50bp, more preferably 20bp-30bp.
在本发明中,所述无缝组装体系包括所述试剂盒中的T5核酸外切酶、DNA聚合酶、单链DNA结合蛋白、组装缓冲液和水。In the present invention, the seamless assembly system includes T5 exonuclease, DNA polymerase, single-stranded DNA binding protein, assembly buffer and water in the kit.
在本发明中,所述线性化载体为1ng-300ng用量时,线性化载体与DNA片段间的摩尔比为1:1-1:10,进一步的优选摩尔比为1:2-1:4。其中,所述线性化载体用量1ng-300ng,进一步的优选为20ng-200ng,更进一步的优选为40ng-120ng。In the present invention, when the amount of the linearized carrier is 1ng-300ng, the molar ratio between the linearized carrier and the DNA fragment is 1:1-1:10, and a further preferred molar ratio is 1:2-1:4. Wherein, the amount of the linearized carrier is 1ng-300ng, more preferably 20ng-200ng, and still more preferably 40ng-120ng.
在本发明中,所述组装反应总反应体系以20μl计,包括以下组分:In the present invention, the total reaction system of the assembly reaction comprises the following components in terms of 20 μl:
在本发明中,所述2×无缝组装体系以400μl计,包括以下组分:In the present invention, the 2×seamless assembly system includes the following components in 400 μl:
在本发明中,所述组装反应的程序为:50±10℃孵育0.1-1.0h后,降温至4℃。In the present invention, the procedure of the assembly reaction is: after incubation at 50±10° C. for 0.1-1.0 h, the temperature is lowered to 4° C.
在本发明中,所述组装反应完成后还包括将获得的组装体系转化到大肠杆菌的感受态细胞中验证的过程;所述感受态细胞优选的包括DH5a、JM109、Top10、GB05、S17-1、CC118、SM10以及XL-1Blue MRF中的任一种。In the present invention, after the completion of the assembly reaction, it also includes the process of transforming the obtained assembly system into competent cells of Escherichia coli for verification; the competent cells preferably include DH5a, JM109, Top10, GB05, S17-1 , CC118, SM10 and any one of XL-1Blue MRF.
下面结合实施例对本发明提供的技术方案进行详细的说明,但是不能把它们理解为对本发明保护范围的限定。The technical solutions provided by the present invention will be described in detail below in conjunction with the examples, but they should not be interpreted as limiting the protection scope of the present invention.
实施例1:TSP试剂盒在两片段、三片段或四片段组装中的应用Example 1: Application of TSP kit in two-fragment, three-fragment or four-fragment assembly
以构建pcDNA3.1-TSHR-EGFP表达载体为例(图2),进行不同数量的DNA片段的重组效率测试。Taking the construction of pcDNA3.1-TSHR-EGFP expression vector as an example (Figure 2), the recombination efficiency test of different numbers of DNA fragments was carried out.
(一)材料配制(1) Material preparation
TSP试剂盒由组装缓冲液、T5核酸外切酶、DNA聚合酶和单链结合蛋白组成;TSP kit consists of assembly buffer, T5 exonuclease, DNA polymerase and single-strand binding protein;
将T5核酸外切酶、DNA聚合酶和单链结合蛋白配制为2×、3×、4×或5×浓度浓缩,为后续添加不等量的DNA做预留;Concentrate T5 exonuclease, DNA polymerase and single-strand binding protein at 2×, 3×, 4× or 5× concentrations, which are reserved for the subsequent addition of varying amounts of DNA;
T5核酸外切酶的用量是0.004U/总反应体系,DNA聚合酶的用量是0.025U/总反应体系,单链结合蛋白的用量是0.003U/总反应体系;The dosage of T5 exonuclease is 0.004U/total reaction system, the dosage of DNA polymerase is 0.025U/total reaction system, and the dosage of single-chain binding protein is 0.003U/total reaction system;
TSP缓冲液组分为100mM,pH=7.5的Tris-HCl,10mM MgCl2,10mM DTT,0.2mM dNTPMix和质量比为5%的PEG8000;TSP buffer components are 100mM Tris-HCl with pH=7.5, 10mM MgCl 2 , 10mM DTT, 0.2mM dNTPMix and PEG8000 with a mass ratio of 5%;
TSP组装体系包括TSP试剂盒和水;TSP assembly system includes TSP kit and water;
上述浓缩条件不同不影响组装效果;试剂盒中三种酶和反应缓冲液为预先混入或者后加入均可;本试剂盒经测试存放于-20℃到-80℃之间的环境中均可,不影响组装效率,在此温度范围内可存放6个月以上,不影响组装效果。The above concentration conditions do not affect the assembly effect; the three enzymes and the reaction buffer in the kit can be pre-mixed or added later; the kit has been tested and stored in an environment between -20°C and -80°C. It does not affect the assembly efficiency, and it can be stored in this temperature range for more than 6 months without affecting the assembly effect.
(二)设计引物(2) Design primers
首先根据载体序列分别设计不同引物将质粒扩增成不同长度的DNA片段,包括由两片段、三片段或四片段,不同DNA片段间用于重组的同源臂序列长度为20bp到30bp不等,该步骤使用的引物如下所述:Firstly, different primers are designed according to the vector sequence to amplify the plasmid into DNA fragments of different lengths, including two fragments, three fragments or four fragments. The length of the homologous arm sequences used for recombination between different DNA fragments ranges from 20bp to 30bp. The primers used in this step are as follows:
Frag-A-F1:TGGATAGCGGTTTGACTCACFrag-A-F1:TGGATAGCGGTTTGACTCAC
Frag-A-R1:GCTTCCTTTGCGGCGGCTTCTAGCTCAGTCTGCTTGCATTFrag-A-R1:GCTTCCTTTGCGGCGGCTTCTAGCTCAGTCTGCTTGCATT
Frag-B-F1:GAAGCCGCCGCAAAGGAAGCTGFrag-B-F1:GAAGCCGCCGCAAAGGAAGCTG
Frag-B-R1:GTGAGTCAAACCGCTATCCAFrag-B-R1: GTGAGTCAAAACCGCTATCCA
Frag-C-F1:GATCAGCCTCGACTGTGCCTFrag-C-F1:GATCAGCCTCGACTGTGCCT
Frag-C-R1:GTGAGTCAAACCGCTATCCAFrag-C-R1:GTGAGTCAAAACCGCTATCCA
Frag-D-F1:GAAGCCGCCGCAAAGGAAGCTGFrag-D-F1:GAAGCCGCCGCAAAGGAAGCTG
Frag-D-R1:TAGAAGGCACAGTCGAGGFrag-D-R1:TAGAAGGCACAGTCGAGG
Frag-E-F1:GATCAGCCTCGACTGTGCCTFrag-E-F1:GATCAGCCTCGACTGTGCCT
Frag-E-R1:AGGTAACTGGCTTCAGCAGAFrag-E-R1:AGGTAACTGGCTTCAGCAGA
Frag-F-F1:GTATCTGCGCTCTGCTGAAGFrag-F-F1:GTATCTGCGCTCTGCTGAAG
Frag-F-R1:GTGAGTCAAACCGCTATCCAFrag-F-R1:GTGAGTCAAAACCGCTATCCA
在两片段(A+B)连接中,使用引物Frag-A-F1和Frag-A-R1扩增得到片段A,使用引物Frag-B-F1和Frag-B-R1扩增得到片段B;In the connection of two fragments (A+B), use primers Frag-A-F1 and Frag-A-R1 to amplify fragment A, and use primers Frag-B-F1 and Frag-B-R1 to amplify fragment B;
在三片段(A+C+D)连接中,使用引物Frag-A-F1和Frag-A-R1扩增得到片段A,使用引物Frag-C-F1和Frag-C-R1扩增得到片段C,使用引物Frag-D-F1和Frag-D-R1扩增得到片段D;In a three-fragment (A+C+D) ligation, use primers Frag-A-F1 and Frag-A-R1 to amplify Fragment A, and use primers Frag-C-F1 and Frag-C-R1 to amplify Fragment C , Fragment D was amplified using primers Frag-D-F1 and Frag-D-R1;
在四片段(A+D+E+F)连接中,使用引物Frag-A-F1和Frag-A-R1扩增得到片段A,使用引物Frag-D-F1和Frag-D-R1扩增得到片段D,使用引物Frag-E-F1和Frag-E-R1扩增得到片段E,使用引物Frag-F-F1和Frag-F-R1扩增得到片段F。In a four-fragment (A+D+E+F) ligation, fragment A was amplified using primers Frag-A-F1 and Frag-A-R1, and fragment A was amplified using primers Frag-D-F1 and Frag-D-R1 Fragment D, Fragment E was amplified using primers Frag-E-F1 and Frag-E-R1, and Fragment F was amplified using primers Frag-F-F1 and Frag-F-R1.
(三)组装片段的PCR扩增(3) PCR amplification of assembled fragments
在50μl总体积反应包含25μl KOD OneTM PCR MasterMix、1.5μl引物F1、1.5μl引物R1、5μl的DNA模板(质粒DNA稀释至≤1μg/ml)和无菌水17μl。Reactions in a total volume of 50 μl contained 25 μl KOD One ™ PCR MasterMix, 1.5 μl primer F1, 1.5 μl primer R1, 5 μl DNA template (plasmid DNA diluted to <1 μg/ml) and sterile water 17 μl.
PCR循环程序如下:第一步:98℃为10秒;第二步:60℃为10秒;第三步:68℃为25秒(5sec./kb);第四步:回到第一步29次;第五步:72℃为5分钟,取出PCR产物储存于4℃或用于后续实验。PCR产物通常在琼脂糖凝胶(1-2%)上进行电泳检测,之后进行切胶回收,按照凝胶回收试剂盒说明书推荐方法回收PCR产物。The PCR cycle program is as follows: Step 1: 10 seconds at 98°C; Step 2: 10 seconds at 60°C; Step 3: 25 seconds at 68°C (5sec./kb); Step 4: Return to Step 1 29 times; the fifth step: 72°C for 5 minutes, take out the PCR product and store it at 4°C or use it for subsequent experiments. The PCR product is usually detected by electrophoresis on an agarose gel (1-2%), and then recovered by cutting the gel. The PCR product is recovered according to the method recommended in the instructions of the gel recovery kit.
(四)组装(4) Assembly
对于2个片段组装,将1μl 40ng/μl的线性化的载体和2μl 60ng/μl的PCR插入物加入到含有10μl 2X TSP组装体系的PCR微管中,将无菌超纯水加入到试管中,补足最终体积为20μl。反应液在50℃下孵育1小时,反应后可冰浴10分钟,即可得到TSP组装产物(如图3中的A)。For 2-fragment assembly, add 1 μl 40ng/μl linearized vector and 2 μl 60ng/μl PCR insert into a PCR microtube containing 10 μl 2X TSP assembly system, add sterile ultrapure water to the tube, Make up to a final volume of 20 μl. The reaction solution was incubated at 50° C. for 1 hour. After the reaction, it could be ice-bathed for 10 minutes to obtain the TSP assembly product (A in FIG. 3 ).
对于3个片段组装,每个插入物使用1μl(40ng/μl,尽量调整不同片段的摩尔比为1:1),其他操作同上。For 3-fragment assembly, use 1 μl (40ng/μl, try to adjust the molar ratio of different fragments to 1:1) for each insert, and the other operations are the same as above.
对于4个片段组装,每个插入物使用1μl(40ng/μl,尽量调整不同片段的摩尔比为1:1),其他操作同上。For 4-fragment assembly, use 1 μl (40ng/μl, try to adjust the molar ratio of different fragments to 1:1) for each insert, and the other operations are the same as above.
(五)转化感受态细胞(5) Transformation Competent Cells
取5μl获得的TSP组装产物添加到DH5α感受态细胞内,加入LB后,37℃250rpm条件下恢复培养1小时,然后将转化产物涂布到含对应抗生素的LB平板上,恒温(37℃)培养16小时后统计克隆数量(如图3中的B)。Take 5 μl of the obtained TSP assembly product and add it to DH5α competent cells. After adding LB, resume culture at 37°C and 250 rpm for 1 hour, then spread the transformation product on the LB plate containing the corresponding antibiotic, and culture at constant temperature (37°C) After 16 hours, the number of clones was counted (as shown in B in Figure 3).
(六)阳性菌落的筛选(6) Screening of positive colonies
此外采用基因特异性引物(Frag-A-F1和Frag-D-R1)进行筛菌PCR实验,以获得阳性率(如图3中的C)。In addition, gene-specific primers (Frag-A-F1 and Frag-D-R1) were used to conduct bacteria screening PCR experiments to obtain the positive rate (C in Figure 3).
阳性率=阳性菌落/总菌落Positive rate = positive colonies / total colonies
在本实例中,为证明本试剂盒配方中添加单链结合蛋白的重要性和优势,设置了对照组TP试剂盒(即Hot Fusion法,参考Fu,Changlin,et al.,PloS one,2014),其与TSP法相比较唯一的不同在于试剂盒中缺少了单链结合蛋白,其他实验条件完全一致。In this example, in order to prove the importance and advantages of adding single-chain binding protein to the kit formula, a control group TP kit (ie Hot Fusion method, refer to Fu, Changlin, et al., PloS one, 2014) was set up , compared with the TSP method, the only difference is that the single-chain binding protein is missing in the kit, and other experimental conditions are exactly the same.
本实例结果如图3所示,图3中的A显示本实例利用PCR成功制备了用于组装的不同大小的DNA片段。The results of this example are shown in Figure 3, and A in Figure 3 shows that DNA fragments of different sizes for assembly were successfully prepared in this example by PCR.
图3中的B揭示TP试剂盒和TSP试剂盒均可以实现不同数量的片段的组装,其中在两片段组装方式中,TSP试剂盒组装所获得的克隆数显著高于TP组,克隆数增加近40%;在三片段组装方式中,TSP试剂盒所获得的克隆数显著增加近410%,极显著地提升了克隆效率;而在四片段组装中,TSP试剂盒获得的克隆数量也显著提升420%。上述结果显示优化的TSP试剂盒在多片段组装中具有极其显著的优势,可以形成更多的克隆数量。B in Figure 3 reveals that both the TP kit and the TSP kit can achieve the assembly of different numbers of fragments, and in the two-fragment assembly method, the number of clones obtained by TSP kit assembly is significantly higher than that of the TP group, and the number of clones increases by nearly 40%; in the three-fragment assembly method, the number of clones obtained by the TSP kit increased significantly by nearly 410%, which greatly improved the cloning efficiency; and in the four-fragment assembly, the number of clones obtained by the TSP kit also significantly increased by 420 %. The above results show that the optimized TSP kit has extremely significant advantages in multi-fragment assembly and can form more clones.
图3中的C中揭示利用基因特异性引物进行菌落PCR的部分结果,首先揭示TP试剂盒和TSP试剂盒组装得到的克隆中均具有大量阳性克隆,可作为一种可靠的DNA片段组装试剂盒;同时,在两片段和三片段组装中,两种试剂盒的阳性率均大于95%;在四片段重组中,TSP试剂盒仍具有超过90%的阳性率,而TP试剂盒的阳性率则接近70%,凸显TSP试剂盒在多片段组装中的高效性和准确性。C in Figure 3 reveals part of the results of colony PCR using gene-specific primers. First, it reveals that there are a large number of positive clones in the clones assembled by the TP kit and the TSP kit, which can be used as a reliable DNA fragment assembly kit ; At the same time, in two-fragment and three-fragment assembly, the positive rate of the two kits is greater than 95%; in four-fragment recombination, the TSP kit still has a positive rate of more than 90%, while the positive rate of the TP kit is Nearly 70%, highlighting the high efficiency and accuracy of the TSP kit in multi-fragment assembly.
实施例2:TSP试剂盒在六片段组装中的应用Example 2: Application of TSP kit in six-fragment assembly
本实施例仍以构建pcDNA3.1-TSHR-EGFP表达载体为例(图4),进行六片段组装的重组应用测试。In this embodiment, the construction of pcDNA3.1-TSHR-EGFP expression vector is still taken as an example ( FIG. 4 ), and the recombination application test of six-fragment assembly is carried out.
(一)材料配制(1) Material preparation
TSP试剂盒由组装缓冲液、T5核酸外切酶、DNA聚合酶和单链结合蛋白组成;TSP kit consists of assembly buffer, T5 exonuclease, DNA polymerase and single-strand binding protein;
将T5核酸外切酶、DNA聚合酶和单链结合蛋白配制为2×、3×、4×或5×浓度浓缩,为后续添加不等量的DNA做预留;Concentrate T5 exonuclease, DNA polymerase and single-strand binding protein at 2×, 3×, 4× or 5× concentrations, which are reserved for the subsequent addition of varying amounts of DNA;
T5核酸外切酶的用量是0.004U/总反应体系,DNA聚合酶的用量是0.025U/总反应体系,单链结合蛋白的用量是0.003U/总反应体系;The dosage of T5 exonuclease is 0.004U/total reaction system, the dosage of DNA polymerase is 0.025U/total reaction system, and the dosage of single-chain binding protein is 0.003U/total reaction system;
TSP缓冲液组分为100mM,pH=7.5的Tris-HCl,10mM MgCl2,10mM DTT,0.2mM dNTPMix和质量比为5%的PEG8000;TSP buffer components are 100mM Tris-HCl with pH=7.5, 10mM MgCl 2 , 10mM DTT, 0.2mM dNTPMix and PEG8000 with a mass ratio of 5%;
TSP组装体系包括TSP试剂盒和水;TSP assembly system includes TSP kit and water;
上述浓缩条件不同不影响组装效果;试剂盒中三种酶和反应缓冲液为预先混入或者后加入均可;本试剂盒经测试存放于-20℃到-80℃之间的环境中均可,不影响组装效率,在此温度范围内可存放6个月以上,不影响组装效果。The above concentration conditions do not affect the assembly effect; the three enzymes and the reaction buffer in the kit can be pre-mixed or added later; the kit has been tested and stored in an environment between -20°C and -80°C. It does not affect the assembly efficiency, and it can be stored in this temperature range for more than 6 months without affecting the assembly effect.
(二)设计引物(2) Design primers
首先根据载体序列分别设计不同引物将质粒扩增成不同长度的六个DNA片段(Frag-Ⅰ至Frag-Ⅵ),不同DNA片段间用于重组的同源臂序列长度为20bp到30bp不等,该步骤使用的引物如下所述:First, different primers were designed according to the vector sequence to amplify the plasmid into six DNA fragments (Frag-I to Frag-VI) of different lengths. The lengths of the homology arm sequences used for recombination between different DNA fragments ranged from 20bp to 30bp. The primers used in this step are as follows:
Frag-Ⅰ-F1:TGGATAGCGGTTTGACTCACFrag-I-F1:TGGATAGCGGTTTGACTCAC
Frag-Ⅰ-R1:GCTTCCTTTGCGGCGGCTTCTAGCTCAGTCTGCTTGCATTFrag-Ⅰ-R1:GCTTCCTTTGCGGCGGCTTCTAGCTCAGTCTGCTTGCATT
Frag-Ⅱ-F1:GAAGCCGCCGCAAAGGAAGCTGFrag-Ⅱ-F1:GAAGCCGCCGCAAAGGAAGCTG
Frag-Ⅱ-R1:TAGAAGGCACAGTCGAGGFrag-Ⅱ-R1:TAGAAGGCACAGTCGAGG
Frag-Ⅲ-F1:GATCAGCCTCGACTGTGCCTFrag-Ⅲ-F1:GATCAGCCTCGACTGTGCCT
Frag-Ⅲ-R1:CGATCCTCATCCTGTCTCTTFrag-Ⅲ-R1:CGATCCTCATCCTGTCTCTT
Frag-Ⅳ-F1:GGATCTGATCAAGAGACAGGFrag-Ⅳ-F1: GGATCTGATCAAGAGACAGG
Frag-Ⅳ-R1:TTACCGCCTTTGAGTGAGCTFrag-Ⅳ-R1: TTACCGCCTTTGAGTGAGCT
Frag-Ⅴ-F1:GAGCGGTATCAGCTCACTCFrag-Ⅴ-F1:GAGCGGTATCAGCTCACTC
Frag-Ⅴ-R1:AGGTAACTGGCTTCAGCAGAFrag-Ⅴ-R1: AGGTAACTGGCTTCAGCAGA
Frag-Ⅵ-F1:GTATCTGCGCTCTGCTGAAGFrag-Ⅵ-F1: GTATCTGCGCTCTGCTGAAG
Frag-Ⅵ-R1:GTGAGTCAAACCGCTATCCAFrag-Ⅵ-R1:GTGAGTCAAACCGCTATCCA
(三)组装片段的PCR扩增(3) PCR amplification of assembled fragments
在50μl总体积反应包含25μl KOD OneTM PCR MasterMix、1.5μl引物F1、1.5μl引物R1、5μl的DNA模板(质粒DNA稀释至≤1μg/ml)和无菌水17μl。Reactions in a total volume of 50 μl contained 25 μl KOD One ™ PCR MasterMix, 1.5 μl primer F1, 1.5 μl primer R1, 5 μl DNA template (plasmid DNA diluted to <1 μg/ml) and sterile water 17 μl.
PCR循环程序如下:第一步:98℃为10秒;第二步:60℃为10秒;第三步:68℃为25秒(5sec./kb);第四步:回到第一步29次;第五步:72℃为5分钟,取出PCR产物储存于4℃或用于后续实验。PCR产物通常在琼脂糖凝胶(1-2%)上进行电泳检测,之后进行切胶回收,按照凝胶回收试剂盒说明书推荐方法回收PCR产物。The PCR cycle program is as follows: Step 1: 10 seconds at 98°C; Step 2: 10 seconds at 60°C; Step 3: 25 seconds at 68°C (5sec./kb); Step 4: Return to Step 1 29 times; the fifth step: 72°C for 5 minutes, take out the PCR product and store it at 4°C or use it for subsequent experiments. The PCR product is usually detected by electrophoresis on an agarose gel (1-2%), and then recovered by cutting the gel. The PCR product is recovered according to the method recommended in the instructions of the gel recovery kit.
(四)组装(4) Assembly
将1μl 40ng/μl的线性化的载体和2μl 40ng/μl的PCR插入物加入到含有10μl 2XTSP组装体系的PCR微管中,将无菌超纯水加入到试管中,补足最终体积为20μl。反应液在50℃下孵育1小时,反应后可冰浴10分钟,即可得到TSP组装产物(如图5中的A)。Add 1 μl of 40ng/μl linearized vector and 2 μl of 40ng/μl PCR insert into a PCR microtube containing 10 μl of 2XTSP assembly system, and add sterile ultrapure water to the tube to make up the final volume to 20 μl. The reaction solution was incubated at 50° C. for 1 hour. After the reaction, it could be ice-bathed for 10 minutes to obtain the TSP assembly product (A in FIG. 5 ).
(五)转化感受态细胞(5) Transformation Competent Cells
取5μl获得的TSP组装产物添加到DH5α感受态细胞内,加入LB后,37℃ 250rpm条件下恢复培养1小时,然后将转化产物涂布到含对应抗生素的LB平板上,恒温(37℃)培养16小时后统计克隆数量(如图5中的B)。Take 5 μl of the obtained TSP assembly product and add it to DH5α competent cells. After adding LB, restore the culture at 37°C and 250rpm for 1 hour, then spread the transformation product on the LB plate containing the corresponding antibiotic, and culture at constant temperature (37°C) After 16 hours, the number of clones was counted (as shown in B in Figure 5).
(六)阳性菌落的筛选(6) Screening of positive colonies
此外采用基因特异性引物(Frag-Ⅰ-F1和Frag-II-R1)进行筛菌PCR实验,以获得阳性率(如图5中的D)。In addition, gene-specific primers (Frag-I-F1 and Frag-II-R1) were used to perform bacteria screening PCR experiments to obtain the positive rate (D in Figure 5).
阳性率=阳性菌落/总菌落Positive rate = positive colonies / total colonies
在本实例中,为证明本试剂盒配方中添加单链结合蛋白的重要性和优势,设置了多个对照组,首先,选择TEDA法,参考Xia,Yongzhen,et al.Nucleic acids research 47.3(2019)的方法配制反应液,其核心在于试剂盒仅使用0.04U/总反应体系的T5核酸外切酶,反应条件为30℃孵育30分钟,其余条件与TSP法相似;其次,选择了TP试剂盒,其与TSP法相比较唯一的不同在于试剂盒中缺少了单链结合蛋白,其他实验条件完全一致;此外,购买的商业化的GibsonAssembly克隆试剂盒,其核心在于与TSP试剂盒相比较,缺少了单链结合蛋白,增加了成本较高的DNA连接酶,其余条件与TSP试剂盒接近。In this example, in order to prove the importance and advantages of adding single-chain binding proteins to the kit formula, multiple control groups were set up. First, the TEDA method was selected, referring to Xia, Yongzhen, et al. Nucleic acids research 47.3 (2019 ) method to prepare the reaction solution, the core of which is that the kit only uses 0.04U/total reaction system of T5 exonuclease, the reaction condition is 30°C for 30 minutes, and the other conditions are similar to the TSP method; secondly, the TP kit was selected , compared with the TSP method, the only difference is that the single-chain binding protein is missing in the kit, and other experimental conditions are exactly the same; in addition, the core of the purchased commercial GibsonAssembly cloning kit is that compared with the TSP kit, it lacks For single-strand binding proteins, a DNA ligase with a higher cost is added, and the remaining conditions are close to those of the TSP kit.
本实例结果如图5所示,上述四种组装方法均可以实现六片段的组装,其中根据平均克隆形成数进行比较,TSP试剂盒形成了最多的克隆数,平均数量约1.65×104colonyforming units(CFU)/μg plasmid,其次是商品化Gibson Assembly试剂盒,平均数量约1.04×104CFU/μg plasmid,再次是TP试剂盒,平均数量约0.32×104CFU/μg plasmid,形成克隆数最少的是TEDA法,平均数量约0.12×104CFU/μgplasmid,四种方法得到的克隆数差异均具有显著性。该结果表明本TSP试剂盒具有最优的克隆数形成能力,其至少在六片段重组上显著优于其他组装方式。The results of this example are shown in Figure 5. The above four assembly methods can all realize the assembly of six fragments. According to the comparison of the average number of colony forming units, the TSP kit formed the largest number of clones, with an average number of about 1.65×10 4 colonyforming units (CFU)/μg plasmaid, followed by the commercial Gibson Assembly kit, the average number is about 1.04×10 4 CFU/μg plasmamid, and the third is the TP kit, the average number is about 0.32×10 4 CFU/μg plasmamid, and the number of clones is the least The TEDA method is used, the average number is about 0.12×10 4 CFU/μgplasmid, and the difference in the number of clones obtained by the four methods is significant. This result shows that this TSP kit has the best ability to form clones, and it is significantly better than other assembly methods at least in six-fragment recombination.
为进一步探究TSP试剂盒的最优条件,测试了其在50℃条件下不同孵育时间下的组装能力,结果如图5中的C所示,其在孵育10分钟后即可获得大量的重组克隆,平均数量约为0.88×104CFU/μg plasmid,在孵育20分钟后获得最多的克隆数,平均数量约2.33×104CFU/μg plasmid,其在40分钟和60分钟时亦可获得大量克隆,平均数量为1.51×104和1.21×104CFU/μgplasmid,揭示TSP的孵育时间在10分钟到60分钟均可,在本实例中20分钟孵育具有最优的效果。In order to further explore the optimal conditions of the TSP kit, its assembly ability was tested under different incubation times at 50°C. The results are shown in C in Figure 5, and a large number of recombinant clones can be obtained after 10 minutes of incubation , the average number is about 0.88×10 4 CFU/μg plasmamid, and the highest number of clones is obtained after 20 minutes of incubation, the average number is about 2.33×10 4 CFU/μg plasmamid, and a large number of clones can also be obtained at 40 minutes and 60 minutes , the average number is 1.51×10 4 and 1.21×10 4 CFU/μgplasmid, revealing that the incubation time of TSP can range from 10 minutes to 60 minutes, and 20 minutes of incubation has the optimal effect in this example.
利用菌落PCR测定克隆阳性率的结果(图5中的D)表明,在形成克隆中,不同时间孵育的TSP试剂盒均具有最优的阳性克隆率,其效率均大于95%;其次是GibsonAssembly法,其阳性率大于80%;而TP法和TEDA法获得的克隆中,阳性率仅在50%左右,极显著低于TSP试剂盒。上述结果揭示本TSP试剂盒具有最优的六片段组装效率,而且具有最高的克隆阳性率;此外,TSP试剂盒在创新性添加单链结合蛋白的基础上,舍弃了高成本DNA连接酶的添加,显著降低了该试剂盒的使用成本。The result (D in Fig. 5) of determining the positive rate of clones by colony PCR shows that in the formation of clones, the TSP kits incubated at different times all have the best positive clone rates, and their efficiencies are all greater than 95%; followed by the GibsonAssembly method , the positive rate is greater than 80%; while the positive rate of the clones obtained by the TP method and TEDA method is only about 50%, which is significantly lower than that of the TSP kit. The above results reveal that this TSP kit has the best six-fragment assembly efficiency and the highest clone positive rate; in addition, the TSP kit abandons the addition of high-cost DNA ligase on the basis of the innovative addition of single-strand binding proteins , significantly reducing the cost of using the kit.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention, it should be pointed out that, for those of ordinary skill in the art, without departing from the principle of the present invention, some improvements and modifications can also be made, and these improvements and modifications can also be made. It should be regarded as the protection scope of the present invention.
序列表 sequence listing
<110> 四川大学<110> Sichuan University
<120> 一种将多个DNA片段和组装载体进行无缝组装的试剂盒及其应用方法<120> A kit for seamlessly assembling multiple DNA fragments and assembly vectors and its application method
<160> 1<160> 1
<170> SIPOSequenceListing 1.0<170> SIPOSequenceListing 1.0
<210> 1<210> 1
<211> 8460<211> 8460
<212> DNA<212>DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 1<400> 1
gacggatcgg gagatctccc gatcccctat ggtgcactct cagtacaatc tgctctgatg 60gacggatcgg gagatctccc gatcccctat ggtgcactct cagtacaatc tgctctgatg 60
ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg 120ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg 120
cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc 180cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc 180
ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt 240ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt 240
gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata 300gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata 300
tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc 360tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc 360
cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc 420cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc 420
attgacgtca atgggtggag tatttacggt aaactgccca cttggcagta catcaagtgt 480attgacgtca atgggtggag tattacggt aaactgccca cttggcagta catcaagtgt 480
atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt 540atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt 540
atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca 600atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca 600
tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg 660tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg 660
actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc 720actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc 720
aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg 780aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg 780
gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca 840gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca 840
ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctagc 900ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctagc 900
gtttaaactt aagcttggta ccgagctcgg ccaccatgct gtggctgcct gtcgccttcc 960gtttaaactt aagcttggta ccgagctcgg ccaccatgct gtggctgcct gtcgccttcc 960
agttggtgct ggtgctgtgc agccagggca cggaaaggtg cccgtcagcc ttctgcgagt 1020agttggtgct ggtgctgtgc agccagggca cggaaaggtg cccgtcagcc ttctgcgagt 1020
gctccgactg ggatgactac aaaattactt gcagggatat ccacttcatt cccagccttc 1080gctccgactg ggatgactac aaaattactt gcagggatat ccacttcatt cccagccttc 1080
cagaggacac tcagaccctg aggtttatgg agacccatct aagaacaatt cccagtgaag 1140cagaggacac tcagaccctg aggtttatgg agacccatct aagaacaatt cccagtgaag 1140
cattttccaa tctccccaac atctctagaa tttatatctc catagatgaa acacttcaga 1200cattttccaa tctccccaac atctctagaa tttatatctc catagatgaa acacttcaga 1200
gtctggaggc ccactccttc aacagcttaa gtaaagtcac tcacattgaa attcgaaatc 1260gtctggaggc ccactccttc aacagcttaa gtaaagtcac tcacattgaa attcgaaatc 1260
ttagaaactt ggattacata gatccagatg cctttaagaa ccttccacta ctgaaatacc 1320ttagaaactt ggattacata gatccagatg cctttaagaa ccttccacta ctgaaatacc 1320
ttggtatttt taatactgga ctcaaggtat ttcctgacct cactaaaatc tattcatctg 1380ttggtatttt taatactgga ctcaaggtat ttcctgacct cactaaaatc tattcatctg 1380
atgtgaactt tttacttgaa attgcagata atcctttcat gacttcagtg cctgcaaatg 1440atgtgaactt tttacttgaa attgcagata atcctttcat gacttcagtg cctgcaaatg 1440
ctttccatgg gctctgcaat gaatctctaa ctctcaaact ctacaataat ggttttacca 1500ctttccatgg gctctgcaat gaatctctaa ctctcaaact ctacaataat ggttttacca 1500
gcatccaagg ccatgctttt aatgggacaa atctggatgc tatctatctg cacaagaaca 1560gcatccaagg ccatgctttt aatgggacaa atctggatgc tatctatctg cacaagaaca 1560
aatacctgaa agttatcaat gaagatgcat ttctgggagt gcatagtgga ccaactctac 1620aatacctgaa agttatcaat gaagatgcat ttctgggagt gcatagtgga ccaactctac 1620
tggatatctc cagaacagtc attgttaatc ttcctgtcaa aggattggaa agccttaaag 1680tggatatctc cagaacagtc attgttaatc ttcctgtcaa aggattggaa agccttaaag 1680
aactaatggc ccggaacaca tggactttaa agaaattacc agctgtaaag atatttctcc 1740aactaatggc ccggaacaca tggactttaa agaaattacc agctgtaaag atatttctcc 1740
agctaattcg agctgatcta tcctatccaa gtcactgctg tgctttcaag aactggaaaa 1800agctaattcg agctgatcta tcctatccaa gtcactgctg tgctttcaag aactggaaaa 1800
aaaacagtgg aattctggag tacttgatgt gtaaccagtc tggcagtcac agttctcgaa 1860aaaacagtgg aattctggag tacttgatgt gtaaccagtc tggcagtcac agttctcgaa 1860
atagaagatc gttcagagct atcagaggac cattttacaa agattatgca gaagaataca 1920atagaagatc gttcagagct atcagaggac cattttacaa agattatgca gaagaataca 1920
cagagcgcac tgatactgtt tatgacaaaa acaccaagtt cacaaatttc catgaaaatt 1980cagagcgcac tgatactgtt tatgacaaaa acaccaagtt cacaaatttc catgaaaatt 1980
cccaatatta tatatttttg gaagagcatg gggaaggaaa tgttgggttt ggccaagagc 2040cccaatatta tatatttttg gaagagcatg gggaaggaaa tgttgggttt ggccaagagc 2040
tcaaaaaccc tcaaactgaa gacatgcagg cctttgacag tcattatgac tatcttgtct 2100tcaaaaaccc tcaaactgaa gacatgcagg cctttgacag tcatttatgac tatcttgtct 2100
gtggaggcag tgaggatgta atatgcactc cagagcctga tgagtttaat ccctgtgagg 2160gtggaggcag tgaggatgta atatgcactc cagagcctga tgagtttaat ccctgtgagg 2160
acataatggg ataccagttt ctgaggattg tggtatggtt tgtgaacctg ctggccatca 2220acataatggg ataccagttt ctgaggattg tggtatggtt tgtgaacctg ctggccatca 2220
taggtaatgt ttttgtcctt tttatccttc taaccagcca ttacaaacta actgtaccac 2280taggtaatgt ttttgtcctt tttatccttc taaccagcca ttacaaacta actgtaccac 2280
gctttcttat gtgcaacctg gcctttgctg atttttgtat ggggttatac cttctcctga 2340gctttcttat gtgcaacctg gcctttgctg atttttgtat ggggttatac cttctcctga 2340
ttgcttcagt ggacctctac accaggtcag agtactataa tcatgctata gagtggcaga 2400ttgcttcagt ggacctctac accagtcag agtactataa tcatgctata gagtggcaga 2400
cagggcctgg ttgcaacaca gcaggtttct tcacagtctt tgctagtgag ctttctgtgt 2460cagggcctgg ttgcaacaca gcaggtttct tcacagtctt tgctagtgag ctttctgtgt 2460
acacacttac tgtgatcacc ctggagcgct ggtatgccat cacctttgcc atgcgtccca 2520acacacttac tgtgatcacc ctggagcgct ggtatgccat cacctttgcc atgcgtccca 2520
atcgaaagat tcgcctccgc catgctttgg ttatcatgct gggaggttgg ctttcatgct 2580atcgaaagat tcgcctccgc catgctttgg ttatcatgct gggaggttgg ctttcatgct 2580
ttcttcttgc ccttttgcca ctggttagag tcagcagcta cagcaaagtc agcatctgct 2640ttcttcttgc ccttttgcca ctggttagag tcagcagcta cagcaaagtc agcatctgct 2640
tacctatgga cactgaaaca ccagtggccg aagcctatgt tgtctttgtt ttaatatgta 2700tacctatgga cactgaaaca ccagtggccg aagcctatgt tgtctttgtt ttaatatgta 2700
acattattgc ttttgtcatc atttgtgcct gctacataaa aatctatatc actgtacgaa 2760acattattgc ttttgtcatc atttgtgcct gctacataaa aatctatatc actgtacgaa 2760
accctcagta taagtcagga gacaaagaca ccaaaattgc caagaggatg gctgtgctga 2820accctcagta taagtcagga gacaaagaca ccaaaattgc caagaggatg gctgtgctga 2820
ttttcactga ctttctgtgc atggctccta tctctttcca tgctctatct gctatcatga 2880ttttcactga ctttctgtgc atggctccta tctctttcca tgctctatct gctatcatga 2880
acaaaccact gataacagtc actaattcca agattttgct ggtacttttc tacccactca 2940acaaaccact gataacagtc actaattcca agattttgct ggtacttttc tacccactca 2940
actcttgcgc caacccattt ctatatgcta ttttcaccaa agctttccga agagatgtgt 3000actcttgcgc caacccattt ctatatgcta ttttcaccaa agctttccga agagatgtgt 3000
ttatcctgct aagcaagttt ggcatatgtg agcatcaggc tcaagtctac agaggtcaaa 3060ttatcctgct aagcaagttt ggcatatgtg agcatcaggc tcaagtctac agaggtcaaa 3060
caatctcagt caaaaacagc agcggctctt acgggcagag aatcagccaa gggataggtc 3120caatctcagt caaaaacagc agcggctctt acgggcagag aatcagccaa gggataggtc 3120
agattcttac aagcatccaa gacccagtca atgattacct tcctgctatg acaatgcaaa 3180agattcttac aagcatccaa gacccagtca atgattacct tcctgctatg acaatgcaaa 3180
accaaattct tgcagaagaa tgcaagcaga ctgagctaga agccgccgca aaggaagctg 3240accaaattct tgcagaagaa tgcaagcaga ctgagctaga agccgccgca aaggaagctg 3240
ctgccaaaga agcagccgct aagatggtga gcaagggcga ggagctgttc accggggtgg 3300ctgccaaaga agcagccgct aagatggtga gcaagggcga ggagctgttc accggggtgg 3300
tgcccatcct ggtcgagctg gacggcgacg taaacggcca caagttcagc gtgtccggcg 3360tgcccatcct ggtcgagctg gacggcgacg taaacggcca caagttcagc gtgtccggcg 3360
agggcgaggg cgatgccacc tacggcaagc tgaccctgaa gttcatctgc accaccggca 3420agggcgaggg cgatgccacc tacggcaagc tgaccctgaa gttcatctgc accaccggca 3420
agctgcccgt gccctggccc accctcgtga ccaccctgac ctacggcgtg cagtgcttca 3480agctgcccgt gccctggccc accctcgtga ccaccctgac ctacggcgtg cagtgcttca 3480
gccgctaccc cgaccacatg aagcagcacg acttcttcaa gtccgccatg cccgaaggct 3540gccgctaccc cgaccacatg aagcagcacg acttcttcaa gtccgccatg cccgaaggct 3540
acgtccagga gcgcaccatc ttcttcaagg acgacggcaa ctacaagacc cgcgccgagg 3600acgtccagga gcgcaccatc ttcttcaagg acgacggcaa ctacaagacc cgcgccgagg 3600
tgaagttcga gggcgacacc ctggtgaacc gcatcgagct gaagggcatc gacttcaagg 3660tgaagttcga gggcgacacc ctggtgaacc gcatcgagct gaagggcatc gacttcaagg 3660
aggacggcaa catcctgggg cacaagctgg agtacaacta caacagccac aacgtctata 3720aggacggcaa catcctgggg cacaagctgg agtacaacta caacagccac aacgtctata 3720
tcatggccga caagcagaag aacggcatca aggtgaactt caagatccgc cacaacatcg 3780tcatggccga caagcagaag aacggcatca aggtgaactt caagatccgc cacaacatcg 3780
aggacggcag cgtgcagctc gccgaccact accagcagaa cacccccatc ggcgacggcc 3840aggacggcag cgtgcagctc gccgaccact accagcagaa cacccccatc ggcgacggcc 3840
ccgtgctgct gcccgacaac cactacctga gcacccagtc cgccctgagc aaagacccca 3900ccgtgctgct gcccgacaac cactacctga gcacccagtc cgccctgagc aaagacccca 3900
acgagaagcg cgatcacatg gtcctgctgg agttcgtgac cgccgccggg atcactctcg 3960acgagaagcg cgatcacatg gtcctgctgg agttcgtgac cgccgccggg atcactctcg 3960
gcatggacga gctgtacaag taagaattct gcagatatcc agcacagtgg cggccgctcg 4020gcatggacga gctgtacaag taagaattct gcagatatcc agcacagtgg cggccgctcg 4020
agtctagagg gcccgtttaa acccgctgat cagcctcgac tgtgccttct agttgccagc 4080agtctagagg gcccgtttaa acccgctgat cagcctcgac tgtgccttct agttgccagc 4080
catctgttgt ttgcccctcc cccgtgcctt ccttgaccct ggaaggtgcc actcccactg 4140catctgttgt ttgcccctcc cccgtgcctt ccttgaccct ggaaggtgcc actcccactg 4140
tcctttccta ataaaatgag gaaattgcat cgcattgtct gagtaggtgt cattctattc 4200tcctttccta ataaaatgag gaaattgcat cgcattgtct gagtaggtgt cattctattc 4200
tggggggtgg ggtggggcag gacagcaagg gggaggattg ggaagacaat agcaggcatg 4260tggggggtgg ggtggggcag gacagcaagg gggaggattg ggaagacaat agcaggcatg 4260
ctggggatgc ggtgggctct atggcttctg aggcggaaag aaccagctgg ggctctaggg 4320ctggggatgc ggtgggctct atggcttctg aggcggaaag aaccagctgg ggctctaggg 4320
ggtatcccca cgcgccctgt agcggcgcat taagcgcggc gggtgtggtg gttacgcgca 4380ggtatcccca cgcgccctgt agcggcgcat taagcgcggc gggtgtggtg gttacgcgca 4380
gcgtgaccgc tacacttgcc agcgccctag cgcccgctcc tttcgctttc ttcccttcct 4440gcgtgaccgc tacacttgcc agcgccctag cgcccgctcc tttcgctttc ttcccttcct 4440
ttctcgccac gttcgccggc tttccccgtc aagctctaaa tcgggggctc cctttagggt 4500ttctcgccac gttcgccggc tttccccgtc aagctctaaa tcgggggctc cctttagggt 4500
tccgatttag tgctttacgg cacctcgacc ccaaaaaact tgattagggt gatggttcac 4560tccgatttag tgctttacgg cacctcgacc ccaaaaaact tgattaggggt gatggttcac 4560
gtagtgggcc atcgccctga tagacggttt ttcgcccttt gacgttggag tccacgttct 4620gtagtgggcc atcgccctga tagacggttt ttcgcccttt gacgttggag tccacgttct 4620
ttaatagtgg actcttgttc caaactggaa caacactcaa ccctatctcg gtctattctt 4680ttaatagtgg actcttgttc caaactggaa caacactcaa ccctatctcg gtctattctt 4680
ttgatttata agggattttg ccgatttcgg cctattggtt aaaaaatgag ctgatttaac 4740ttgatttata agggattttg ccgatttcgg cctattggtt aaaaaatgag ctgatttaac 4740
aaaaatttaa cgcgaattaa ttctgtggaa tgtgtgtcag ttagggtgtg gaaagtcccc 4800aaaaatttaa cgcgaattaa ttctgtggaa tgtgtgtcag ttagggtgtg gaaagtcccc 4800
aggctcccca gcaggcagaa gtatgcaaag catgcatctc aattagtcag caaccaggtg 4860aggctcccca gcaggcagaa gtatgcaaag catgcatctc aattagtcag caaccaggtg 4860
tggaaagtcc ccaggctccc cagcaggcag aagtatgcaa agcatgcatc tcaattagtc 4920tggaaagtcc ccaggctccc cagcaggcag aagtatgcaa agcatgcatc tcaattagtc 4920
agcaaccata gtcccgcccc taactccgcc catcccgccc ctaactccgc ccagttccgc 4980agcaaccata gtcccgcccc taactccgcc catcccgccc ctaactccgc ccagttccgc 4980
ccattctccg ccccatggct gactaatttt ttttatttat gcagaggccg aggccgcctc 5040ccattctccg ccccatggct gactaatttt ttttattatt gcagaggccg aggccgcctc 5040
tgcctctgag ctattccaga agtagtgagg aggctttttt ggaggcctag gcttttgcaa 5100tgcctctgag ctattccaga agtagtgagg aggctttttt ggaggcctag gcttttgcaa 5100
aaagctcccg ggagcttgta tatccatttt cggatctgat caagagacag gatgaggatc 5160aaagctcccg ggagcttgta tatccatttt cggatctgat caagagacag gatgaggatc 5160
gtttcgcatg attgaacaag atggattgca cgcaggttct ccggccgctt gggtggagag 5220gtttcgcatg attgaacaag atggattgca cgcaggttct ccggccgctt gggtggagag 5220
gctattcggc tatgactggg cacaacagac aatcggctgc tctgatgccg ccgtgttccg 5280gctattcggc tatgactggg cacaacagac aatcggctgc tctgatgccg ccgtgttccg 5280
gctgtcagcg caggggcgcc cggttctttt tgtcaagacc gacctgtccg gtgccctgaa 5340gctgtcagcg caggggcgcc cggttctttt tgtcaagacc gacctgtccg gtgccctgaa 5340
tgaactgcag gacgaggcag cgcggctatc gtggctggcc acgacgggcg ttccttgcgc 5400tgaactgcag gacgaggcag cgcggctatc gtggctggcc acgacgggcg ttccttgcgc 5400
agctgtgctc gacgttgtca ctgaagcggg aagggactgg ctgctattgg gcgaagtgcc 5460agctgtgctc gacgttgtca ctgaagcggg aagggactgg ctgctattgg gcgaagtgcc 5460
ggggcaggat ctcctgtcat ctcaccttgc tcctgccgag aaagtatcca tcatggctga 5520ggggcaggat ctcctgtcat ctcaccttgc tcctgccgag aaagtatcca tcatggctga 5520
tgcaatgcgg cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 5580tgcaatgcgg cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 5580
acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc aggatgatct 5640acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc aggatgatct 5640
ggacgaagag catcaggggc tcgcgccagc cgaactgttc gccaggctca aggcgcgcat 5700ggacgaagag catcaggggc tcgcgccagc cgaactgttc gccaggctca aggcgcgcat 5700
gcccgacggc gaggatctcg tcgtgaccca tggcgatgcc tgcttgccga atatcatggt 5760gcccgacggc gaggatctcg tcgtgaccca tggcgatgcc tgcttgccga atatcatggt 5760
ggaaaatggc cgcttttctg gattcatcga ctgtggccgg ctgggtgtgg cggaccgcta 5820ggaaaatggc cgcttttctg gattcatcga ctgtggccgg ctgggtgtgg cggaccgcta 5820
tcaggacata gcgttggcta cccgtgatat tgctgaagag cttggcggcg aatgggctga 5880tcaggacata gcgttggcta cccgtgatat tgctgaagag cttggcggcg aatgggctga 5880
ccgcttcctc gtgctttacg gtatcgccgc tcccgattcg cagcgcatcg ccttctatcg 5940ccgcttcctc gtgctttacg gtatcgccgc tcccgattcg cagcgcatcg ccttctatcg 5940
ccttcttgac gagttcttct gagcgggact ctggggttcg aaatgaccga ccaagcgacg 6000ccttcttgac gagttcttct gagcgggact ctggggttcg aaatgaccga ccaagcgacg 6000
cccaacctgc catcacgaga tttcgattcc accgccgcct tctatgaaag gttgggcttc 6060cccaacctgc catcacgaga tttcgattcc accgccgcct tctatgaaag gttgggcttc 6060
ggaatcgttt tccgggacgc cggctggatg atcctccagc gcggggatct catgctggag 6120ggaatcgttt tccgggacgc cggctggatg atcctccagc gcggggatct catgctggag 6120
ttcttcgccc accccaactt gtttattgca gcttataatg gttacaaata aagcaatagc 6180ttcttcgccc accccaactt gtttattgca gcttataatg gttacaaata aagcaatagc 6180
atcacaaatt tcacaaataa agcatttttt tcactgcatt ctagttgtgg tttgtccaaa 6240atcacaaatt tcacaaataa agcatttttt tcactgcatt ctagttgtgg tttgtccaaa 6240
ctcatcaatg tatcttatca tgtctgtata ccgtcgacct ctagctagag cttggcgtaa 6300ctcatcaatg tatcttatca tgtctgtata ccgtcgacct ctagctagag cttggcgtaa 6300
tcatggtcat agctgtttcc tgtgtgaaat tgttatccgc tcacaattcc acacaacata 6360tcatggtcat agctgtttcc tgtgtgaaat tgttatccgc tcacaattcc acacaacata 6360
cgagccggaa gcataaagtg taaagcctgg ggtgcctaat gagtgagcta actcacatta 6420cgagccggaa gcataaagtg taaagcctgg ggtgcctaat gagtgagcta actcacatta 6420
attgcgttgc gctcactgcc cgctttccag tcgggaaacc tgtcgtgcca gctgcattaa 6480attgcgttgc gctcactgcc cgctttccag tcgggaaacc tgtcgtgcca gctgcattaa 6480
tgaatcggcc aacgcgcggg gagaggcggt ttgcgtattg ggcgctcttc cgcttcctcg 6540tgaatcggcc aacgcgcggg gagaggcggt ttgcgtattg ggcgctcttc cgcttcctcg 6540
ctcactgact cgctgcgctc ggtcgttcgg ctgcggcgag cggtatcagc tcactcaaag 6600ctcactgact cgctgcgctc ggtcgttcgg ctgcggcgag cggtatcagc tcactcaaag 6600
gcggtaatac ggttatccac agaatcaggg gataacgcag gaaagaacat gtgagcaaaa 6660gcggtaatac ggttatccac agaatcaggg gataacgcag gaaagaacat gtgagcaaaa 6660
ggccagcaaa aggccaggaa ccgtaaaaag gccgcgttgc tggcgttttt ccataggctc 6720ggccagcaaa aggccaggaa ccgtaaaaag gccgcgttgc tggcgttttt ccataggctc 6720
cgcccccctg acgagcatca caaaaatcga cgctcaagtc agaggtggcg aaacccgaca 6780cgcccccctg acgagcatca caaaaatcga cgctcaagtc agaggtggcg aaacccgaca 6780
ggactataaa gataccaggc gtttccccct ggaagctccc tcgtgcgctc tcctgttccg 6840ggactataaa gataccaggc gtttccccct ggaagctccc tcgtgcgctc tcctgttccg 6840
accctgccgc ttaccggata cctgtccgcc tttctccctt cgggaagcgt ggcgctttct 6900accctgccgc ttaccggata cctgtccgcc tttctccctt cgggaagcgt ggcgctttct 6900
catagctcac gctgtaggta tctcagttcg gtgtaggtcg ttcgctccaa gctgggctgt 6960catagctcac gctgtaggta tctcagttcg gtgtaggtcg ttcgctccaa gctgggctgt 6960
gtgcacgaac cccccgttca gcccgaccgc tgcgccttat ccggtaacta tcgtcttgag 7020gtgcacgaac cccccgttca gcccgaccgc tgcgccttat ccggtaacta tcgtcttgag 7020
tccaacccgg taagacacga cttatcgcca ctggcagcag ccactggtaa caggattagc 7080tccaacccgg taagacacga cttatcgcca ctggcagcag ccactggtaa caggattagc 7080
agagcgaggt atgtaggcgg tgctacagag ttcttgaagt ggtggcctaa ctacggctac 7140agagcgaggt atgtaggcgg tgctacagag ttcttgaagt ggtggcctaa ctacggctac 7140
actagaagaa cagtatttgg tatctgcgct ctgctgaagc cagttacctt cggaaaaaga 7200actagaagaa cagtatttgg tatctgcgct ctgctgaagc cagttacctt cggaaaaaga 7200
gttggtagct cttgatccgg caaacaaacc accgctggta gcggtttttt tgtttgcaag 7260gttggtagct cttgatccgg caaacaaacc accgctggta gcggtttttt tgtttgcaag 7260
cagcagatta cgcgcagaaa aaaaggatct caagaagatc ctttgatctt ttctacgggg 7320cagcagatta cgcgcagaaa aaaaggatct caagaagatc ctttgatctt ttctacgggg 7320
tctgacgctc agtggaacga aaactcacgt taagggattt tggtcatgag attatcaaaa 7380tctgacgctc agtggaacga aaactcacgt taagggattt tggtcatgag attatcaaaa 7380
aggatcttca cctagatcct tttaaattaa aaatgaagtt ttaaatcaat ctaaagtata 7440aggatcttca cctagatcct tttaaattaa aaatgaagtt ttaaatcaat ctaaagtata 7440
tatgagtaaa cttggtctga cagttaccaa tgcttaatca gtgaggcacc tatctcagcg 7500tatgagtaaa cttggtctga cagttaccaa tgcttaatca gtgaggcacc tatctcagcg 7500
atctgtctat ttcgttcatc catagttgcc tgactccccg tcgtgtagat aactacgata 7560atctgtctat ttcgttcatc catagttgcc tgactccccg tcgtgtagat aactacgata 7560
cgggagggct taccatctgg ccccagtgct gcaatgatac cgcgagaccc acgctcaccg 7620cgggaggggct taccatctgg ccccagtgct gcaatgatac cgcgagaccc acgctcaccg 7620
gctccagatt tatcagcaat aaaccagcca gccggaaggg ccgagcgcag aagtggtcct 7680gctccagatt tatcagcaat aaaccagcca gccggaaggg ccgagcgcag aagtggtcct 7680
gcaactttat ccgcctccat ccagtctatt aattgttgcc gggaagctag agtaagtagt 7740gcaactttat ccgcctccat ccagtctatt aattgttgcc gggaagctag agtaagtagt 7740
tcgccagtta atagtttgcg caacgttgtt gccattgcta caggcatcgt ggtgtcacgc 7800tcgccagtta atagtttgcg caacgttgtt gccattgcta caggcatcgt ggtgtcacgc 7800
tcgtcgtttg gtatggcttc attcagctcc ggttcccaac gatcaaggcg agttacatga 7860tcgtcgtttg gtatggcttc attcagctcc ggttcccaac gatcaaggcg agttacatga 7860
tcccccatgt tgtgcaaaaa agcggttagc tccttcggtc ctccgatcgt tgtcagaagt 7920tcccccatgt tgtgcaaaaa agcggttagc tccttcggtc ctccgatcgt tgtcagaagt 7920
aagttggccg cagtgttatc actcatggtt atggcagcac tgcataattc tcttactgtc 7980aagttggccg cagtgttatc actcatggtt atggcagcac tgcataattc tcttactgtc 7980
atgccatccg taagatgctt ttctgtgact ggtgagtact caaccaagtc attctgagaa 8040atgccatccg taagatgctt ttctgtgact ggtgagtact caaccaagtc attctgagaa 8040
tagtgtatgc ggcgaccgag ttgctcttgc ccggcgtcaa tacgggataa taccgcgcca 8100tagtgtatgc ggcgaccgag ttgctcttgc ccggcgtcaa tacgggataa taccgcgcca 8100
catagcagaa ctttaaaagt gctcatcatt ggaaaacgtt cttcggggcg aaaactctca 8160catagcagaa ctttaaaagt gctcatcatt ggaaaacgtt cttcggggcg aaaactctca 8160
aggatcttac cgctgttgag atccagttcg atgtaaccca ctcgtgcacc caactgatct 8220aggatcttac cgctgttgag atccagttcg atgtaaccca ctcgtgcacc caactgatct 8220
tcagcatctt ttactttcac cagcgtttct gggtgagcaa aaacaggaag gcaaaatgcc 8280tcagcatctt ttactttcac cagcgtttct gggtgagcaa aaacaggaag gcaaaatgcc 8280
gcaaaaaagg gaataagggc gacacggaaa tgttgaatac tcatactctt cctttttcaa 8340gcaaaaaagg gaataagggc gacacggaaa tgttgaatac tcatactctt cctttttcaa 8340
tattattgaa gcatttatca gggttattgt ctcatgagcg gatacatatt tgaatgtatt 8400tattattgaa gcatttatca gggttatgt ctcatgagcg gatacatatt tgaatgtatt 8400
tagaaaaata aacaaatagg ggttccgcgc acatttcccc gaaaagtgcc acctgacgtc 8460tagaaaaata aacaaatagg ggttccgcgc aatttcccc gaaaagtgcc acctgacgtc 8460
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210749493.3A CN114875098B (en) | 2022-06-29 | 2022-06-29 | Kit for carrying out seamless assembly on multiple DNA fragments and assembly vector and application method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210749493.3A CN114875098B (en) | 2022-06-29 | 2022-06-29 | Kit for carrying out seamless assembly on multiple DNA fragments and assembly vector and application method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114875098A CN114875098A (en) | 2022-08-09 |
| CN114875098B true CN114875098B (en) | 2023-03-28 |
Family
ID=82683602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210749493.3A Active CN114875098B (en) | 2022-06-29 | 2022-06-29 | Kit for carrying out seamless assembly on multiple DNA fragments and assembly vector and application method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114875098B (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180216098A1 (en) * | 2014-08-27 | 2018-08-02 | New England Biolabs, Inc. | Synthon Formation |
| CN107760706A (en) * | 2017-10-11 | 2018-03-06 | 吴江近岸蛋白质科技有限公司 | The application of DNA excision enzymes and the method for seamless clone |
| CN108841901B (en) * | 2018-07-16 | 2022-03-15 | 山东大学 | Kit for completing DNA assembly by relying on T5 exonuclease and PEG8000 and application thereof |
-
2022
- 2022-06-29 CN CN202210749493.3A patent/CN114875098B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN114875098A (en) | 2022-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014356427B2 (en) | Stable episomes based on non-integrative lentiviral vectors | |
| AU2017201235C1 (en) | Compositions and methods for the treatment of hemoglobinopathies | |
| KR20230091894A (en) | Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (PASTE) | |
| CN110117577B (en) | Low-toxicity herpes simplex virus system and construction method and application thereof | |
| KR20190076993A (en) | A manipulated two-part cell device for the discovery and characterization of T-cell receptor interactions with cognate antigens | |
| AU2017248656A1 (en) | Novel AAV8 mutant capsids and compositions containing same | |
| KR102584628B1 (en) | An engineered multicomponent system for the identification and characterization of T-cell receptors, T-cell antigens, and their functional interactions. | |
| KR102614328B1 (en) | Two-part device for T-cell receptor synthesis and stable genomic integration into TCR-presenting cells | |
| CN107384920B (en) | A base editing system based on Streptococcus pyogenes and its application in gene editing | |
| CN114908087B (en) | Construction and application of long-circulating kidney-targeted extracellular vesicles | |
| CN103149111A (en) | Method for detecting odor substance butanedione based on olfactory receptor sensor | |
| KR20190076991A (en) | A manipulated multicomponent system for identification and characterization of T-cell receptors and T-cell antigens | |
| DK2788489T3 (en) | VECTORS THAT HAVE TOXIC GENES, AND RELATED PROCEDURES AND APPLICATIONS | |
| CN114875098B (en) | Kit for carrying out seamless assembly on multiple DNA fragments and assembly vector and application method thereof | |
| CN109321571A (en) | A method of utilizing CRISPR/Cas9 preparation and reorganization porcine pseudorabies virus | |
| CN110218739B (en) | A reporter gene imaging probe for monitoring pre-mRNA splicing process and its construction method | |
| WO2021042050A1 (en) | Rna-regulated fusion proteins and methods of their use | |
| CN112778425B (en) | Preparation method of RNA gene editing system for reducing off-target effect | |
| CN101705246A (en) | Lentiviral gene transfer vector, preparation method and application thereof | |
| KR101875355B1 (en) | Expression vector library including DNA sequence encoding signal peptide for extracellular secretion of target protein | |
| CN111041027B (en) | Construction method and application of Atg12 gene knockout cell line | |
| CN112779227B (en) | A chimeric canine distemper virus strain and its construction method and application | |
| CN110656088A (en) | Cell model for stably expressing human CaSR gene and construction method thereof | |
| CN106636200B (en) | A kind of the RNA interference plasmid and its application method of ZNF667 albumen | |
| CN113005092A (en) | Preparation method and application of PD1 knockout LMP1 targeted CAR-T cell |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |